Rockwell Medical Inc RMTI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/23/22 EDT
1.72quote price arrow up+0.05 (+2.99%)
Volume
1,929
Close
1.67UNCH (UNCH)
Volume
65,217
52 week range
1.62 - 11.66
Loading...
  • Open1.67
  • Day High1.73
  • Day Low1.64
  • Prev Close1.67
  • 52 Week High11.66
  • 52 Week High Date06/11/21
  • 52 Week Low1.62
  • 52 Week Low Date05/20/22

Key Stats

  • Market Cap14.25M
  • Shares Out8.53M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change-62.97

KEY STATS

  • Open1.67
  • Day High1.73
  • Day Low1.64
  • Prev Close1.67
  • 52 Week High11.66
  • 52 Week High Date06/11/21
  • 52 Week Low1.62
  • 52 Week Low Date05/20/22
  • Market Cap14.25M
  • Shares Out8.53M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change-62.97

RATIOS/PROFITABILITY

  • EPS (TTM)-3.80
  • P/E (TTM)-0.44
  • Fwd P/E (NTM)-0.45
  • EBITDA (TTM)-29.112M
  • ROE (TTM)-121.86%
  • Revenue (TTM)61.76M
  • Gross Margin (TTM)0.32%
  • Net Margin (TTM)-52.45%
  • Debt To Equity (MRQ)203.15%

EVENTS

  • Earnings Date08/13/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Rockwell Medical Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Rockwell Medical, Inc. is a commercial-stage, biopharmaceutical company. The Company is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. It is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The Company has developed therapies namely Triferic and Triferic AVNU from its FPC platform. The Company’s products from its FPC...
John Mclaughlin J.D.
Independent Chairman of the Board
Russell Ellison M.D.
President, Chief Executive Officer, Director
Russell Skibsted
Executive Vice President, Chief Financial Officer, Chief Business Officer
Paul McGarry
Principal Accounting Officer, Vice President, Corporate Controller
Address
30142 WIXOM ROAD
Wixom, MI
48393
United States

Top Peers

SYMBOLLASTCHG%CHG
NBY
NovaBay Pharmaceuticals Inc
0.20+0.001+0.50%
ULUR
ULURU Inc
0.1749UNCHUNCH
SINT
SINTX Technologies Inc
0.4449+0.0145+3.37%
MLSS
Milestone Scientific Inc
0.87+0.0138+1.58%
QIPT
Quipt Home Medical Corp
4.61+0.23+5.22%